Related Experiment Video

Updated: Aug 10, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Lessons from cholesterol-lowering trials

S C Smith1

  • 1Division of Cardiology, Center for Cardiovascular Disease, University of North Carolina, Chapel Hill 27599-7075, USA.

The American Journal of Medicine
|July 31, 1998
PubMed

Insights

Coronary artery disease (CAD) affects millions, but cholesterol-lowering therapies, like HMG-CoA reductase inhibitors, significantly reduce mortality. Wider adoption of these preventive treatments is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Coronary artery disease (CAD) is a leading cause of morbidity and mortality, affecting over 13 million individuals.
  • CAD underlies approximately 2 million cases of congestive heart failure, contributing significantly to healthcare costs.
  • Current spending on preventive therapies for heart disease remains suboptimal despite proven benefits.

Purpose of the Study:

  • To highlight the effectiveness of cholesterol-lowering therapies in reducing cardiovascular mortality.
  • To emphasize the need for improved clinical application of findings from recent cholesterol-lowering trials.
  • To advocate for increased focus on primary and secondary prevention strategies in CAD management.

Main Methods:

  • Review of recent clinical trials on cholesterol-lowering therapies.
  • Analysis of current treatment patterns and goal attainment in patients with CAD.
  • Evaluation of the impact of HMG-CoA reductase inhibitors on cardiovascular events and healthcare utilization.

Main Results:

  • Cholesterol-lowering therapies, particularly HMG-CoA reductase inhibitors, significantly reduce mortality from cardiovascular events.
  • These therapies decrease the need for costly hospitalizations and revascularization procedures.
  • Less than half of CAD patients receive cholesterol-lowering therapy, and few achieve their low-density lipoprotein (LDL) cholesterol goals.

Conclusions:

  • Cholesterol-lowering therapy is a critical component of managing coronary artery disease.
  • Clinicians must prioritize the implementation of evidence-based preventive strategies, including statin therapy.
  • Improving patient adherence and achieving LDL cholesterol targets are essential for reducing CAD-related morbidity and mortality.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...